All Stories

  1. Emergency Services of Viral RNAs: Repair and Remodeling
  2. Pressure for Pattern-Specific Intertypic Recombination between Sabin Polioviruses: Evolutionary Implications
  3. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus
  4. Mutational robustness and resilience of a replicative cis-element of RNA virus: Promiscuity, limitations, relevance
  5. Attachment and Invasion of the Respiratory Tract
  6. Picornavirus Genetics: an Overview
  7. Picornavirus Genome: an Overview
  8. Cytopathic effects: virus-modulated manifestations of innate immunity?
  9. Viral security proteins: counteracting host defences
  10. Immunisation against poliomyelitis: moving forward
  11. Vaccination against polio should not be stopped
  12. Significance of the C-terminal amino acid residue in mengovirus RNA-dependent RNA polymerase
  13. Vaccine-derived polioviruses
  14. Don't drop current vaccine until we have new ones
  15. Variability in apoptotic response to poliovirus infection
  16. Apoptosis-related fragmentation, translocation, and properties of human prothymosin alpha
  17. Long-Term Circulation of Vaccine-Derived Poliovirus That Causes Paralytic Disease
  18. Early Alteration of Nucleocytoplasmic Traffic Induced by Some RNA Viruses
  19. Cross-talk between orientation-dependent recognition determinants of a complex control RNA element, the enterovirus oriR
  20. Prothymosin α fragmentation in apoptosis
  21. Paradoxes of the replication of picornaviral genomes
  22. Two Types of Death of Poliovirus-Infected Cells: Caspase Involvement in the Apoptosis but Not Cytopathic Effect
  23. Recombination and Other Genomic Rearrangements in Picornaviruses
  24. Final checkpoint in the drug-promoted and poliovirus-promoted apoptosis is under post-translational control by growth factors
  25. Final checkpoint in the drug‐promoted and poliovirus‐promoted apoptosis is under post‐translational control by growth factors
  26. Poliovirus Neurovirulence Correlates with the Presence of a Cryptic AUG Upstream of the Initiator Codon
  27. Modification of translational control elements as a new approach to design of attenuated picornavirus strains
  28. A model for rearrangements in RNA genomes
  29. Starting Window, a Distinct Element in the Cap-independent Internal Initiation of Translation on Picornaviral RNA
  30. Genetic studies on the poliovirus 2C protein, an NTPase A plausible mechanism of guanidine effect on the 2C function and evidence for the importance of 2C oligomerization
  31. Russian Contribution to OPV
  32. Poliovirus Neurovirulence and its Attenuation
  33. Towards identification ofcis-acting elements involved in the replication of enterovirus and rhinovirus RNAs: a proposal for the existence of tRNA-like terminal structures
  34. Prokaryotic-like cis elements in the cap-independent internal initiation of translation on picornavirus RNA
  35. Coupled mutations in the 5'-untranslated region of the Sabin poliovirus strains during in vivo passages: structural and functional implications
  36. The 5′-Untranslated Region of Picornaviral Genomes
  37. Gross rearrangements within the 5′-untranslated region of the picornaviral genomes
  38. Distinct modes of poliovirus polyprotein initiation in vitro
  39. Conserved structural domains in the 5′-untranslated region of picornaviral genomes: An analysis of the segment controlling translation and neurovirulence
  40. Point mutations modify the response of poliovirus RNA to a translation initiation factor: A comparison of neurovirulent and attenuated strains
  41. Small cytoplasmic RNA from mouse cells covalently linked to a protein
  42. Studies on the recombination between RNA genomes of poliovirus: The primary structure and nonrandom distribution of crossover regions in the genomes of intertypic poliovirus recombinants
  43. The primary structure of crossover regions of intertypic poliovirus recombinants: A model of recombination between RNA genomes
  44. The Genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies
  45. Encephalomyocarditis virus replication complexes preferentially utilizing nucleoside diphosphates as substrates for viral RNA synthesis. Nucleotide kinases specifically associated with the complex channel RNA precursor
  46. Differences between translation products of tick-borne encephalitis virus RNA in cell-free systems from Krebs-2 cells and rabbit reticulocytes: Involvement of membranes in the processing of nascent precursors of flavivirus structural proteins
  47. Encephalomyocarditis virus replication complexes that Prefer nucleoside diphosphates as substrates for viral RNA synthesis
  48. Translational Barrier in Central Region of Encephalomyocarditis Virus Genome. Modulation by Elongation Factor 2 (eEF-2)
  49. Intertypic recombination in poliovirus: Genetic and biochemical studies
  50. An RNA-Dependent Nucleoside Triphosphate Hydrolase from Krebs-II Ascites Tumor Cells. Detection and Preliminary Characterization
  51. Towards the system of viruses
  52. Efficiency of Translation of Viral and Cellular mRNA’s in Extracts from Cells Infected with Encephalomyocarditis Virus
  53. Picornaviruses as a Model for Studying the Nature of RNA Recombination
  54. The Origin and Evolution of Viruses